826 filings
Page 3 of 42
F-3/A
5w2 gi4ajjipg
23 Oct 23
Shelf registration (foreign) (amended)
4:06pm
6-K
ltc77s6w8kxep
16 Oct 23
Current report (foreign)
4:05pm
F-3
4euxdme nbsv
13 Oct 23
Shelf registration (foreign)
8:13am
D
om0mq4i 1mejwc
12 Oct 23
$4.04 mm in equity / options / securities to be acquired, sold $4.04 mm, 3 investors
4:05pm
6-K
abu4ikq5f0i3s
10 Oct 23
Current report (foreign)
9:08am
6-K
js18 6w1azl
3 Oct 23
Current report (foreign)
7:03am
6-K
fkq1d2
29 Sep 23
Current report (foreign)
8:02am
6-K
jbq4 t5bdk0be
22 Sep 23
Current report (foreign)
4:17pm
6-K
z50407mo yt1vjc30y6
18 Sep 23
Current report (foreign)
7:03am
6-K
j5efdtnbtda2nn
5 Sep 23
Current report (foreign)
7:03am
6-K
n7kmme5xttt3c
17 Aug 23
RedHill Biopharma Provides H1/23 Financial Results and Operational Highlights
7:07am
EFFECT
gm2qn8s7u3 54iqd
14 Aug 23
Notice of effectiveness
12:15am
424B3
s8828nbtjqf6
11 Aug 23
Prospectus supplement
4:52pm
6-K
d99vpdnif5q6l
9 Aug 23
Current report (foreign)
9:00am
UPLOAD
dz2tzl1j n9d2l
9 Aug 23
Letter from SEC
12:00am
CORRESP
789uoqigxq44p3a1dj
9 Aug 23
Correspondence with SEC
12:00am
6-K
mu7tq2nmkjgv4
8 Aug 23
Current report (foreign)
9:00am
D
0c4chh mt8k
7 Aug 23
$2.70 mm in equity / options / securities to be acquired, sold $2.70 mm, 1 investor
4:05pm
F-3
5hs1sj
4 Aug 23
Shelf registration (foreign)
4:05pm
6-K
42gm7qoaj2blh1
1 Aug 23
Current report (foreign)
7:04am